Navigation Links
Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
Date:6/27/2011

43 necessary to complete an Investigational New Drug application, which it plans to submit to the U.S. Food and Drug Administration next month.

"These studies add to our growing collection of data regarding the activity of our compounds and their potential ability to enhance the effects of current treatments," said Robert D. Mass, MD, Chief Medical Officer of Marshall Edwards. "These data further support the clinical development strategy for our lead candidate NV-143, the primary metabolite of Triphendiol, in combination with standard-of-care chemotherapy, while expanding the potential drug combinations we can consider in our randomized Phase II clinical trials."

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's lead programs focus on two families of small molecules that result in the inhibition of tumor cell metabolism. The first and most advanced is a NADH oxidase inhibitor program that includes Triphendiol and lead drug candidate NV-143. The second is a mitochondrial inhibitor program that includes NV-128 and its next-generation candidate NV-344. Both programs are expected to advance into the clinic in 2011. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statem
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
2. Marshall Edwards Announces Private Placement
3. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
4. Marshall Edwards Receives Positive Response From NASDAQ
5. Marshall Edwards to Host Annual Meeting of Stockholders
6. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
7. Marshall Edwards Announces Presentation of New Data Showing Activity in Chemotherapy-Resistant Ovarian Cancer Cells
8. Edwards Lifesciences Announces First Implants in U.S. Study of Minimally-Invasive Pulmonic Valve
9. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
10. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
11. Curaxis Pharmaceutical Corporation Announces Key Changes to Its Board of Directors and Management Team in Progression Toward Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... BELLEVUE, Wash. , June 19, 2013 ... Provisioning version 4.0, a solution designed to ... to applications and data while supporting their ... release of Provisioning represents a milestone in ... governance and analytics capabilities for health systems. ...
(Date:6/19/2013)... , June 19, 2013  Finesse Solutions, Inc, ... life sciences process applications, announced the launch of ... upstream cell culture and fermentation.  The 3L glass ... family of Finesse bioreactors and are designed to ... They are fully compatible with all Finesse G3Lab ...
(Date:6/19/2013)... LARKSPUR, Calif. , June 19, 2013 /PRNewswire/ ... to improve sample standardization and handling in many ... the issuance of new patents by the U.S. ... company,s thermo-conductive products developed to standardize sample handling ... accuracy of results in common laboratory procedures. ...
Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... Jan. 31, 2012  Kerry Ingredients & Flavours is expanding ... include a new Cell Science laboratory. Building on the ... the new Cell Science laboratory will incorporate state-of-the-art technologies ... bio-pharma customers and technology partners. "The ...
... Jan. 31, 2012  Par Pharmaceutical Companies, Inc. (NYSE: PRX ... live webcast on Tuesday, February 28, 2012 at 9:00 AM EST ... The Company will release its financial results on February 28, 2012 ... can be made via the Company,s website at www.parpharm.com . ...
Cached Medicine Technology:Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally 2
(Date:6/19/2013)... 19, 2013 Ultimate Medical Academy (UMA) ... 11.5-hour broadcast on WFLA News Channel 8. Since its ... than $84 million for All Children's Hospital in St. ... "30 Years of Miracles," marked the second year UMA ... employees worked the phones during the Telethon, which raised ...
(Date:6/19/2013)... 2013 The former internist for the ... MD, now serves as director of prevention and wellness ... his own personal encounter with a metabolic syndrome diagnosis ... Over Knives , that he credits with sparking the ... his medical practice. , “The average medical student gets ...
(Date:6/19/2013)... 19, 2013 Next Thursday, June ... kids entertainment media organization, and Muzzy Lane ... will be introducing the Games for Health community ... game is geared toward students in grades 4-7 ... lifestyles by rewarding positive choices. The game is ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... Recently, SoCal CEO Magazine staff was ... their third in a series of six workshops where people with ... helped place the mosaic tiles in their permanent location under the ... and Greg Maxwell. , This mural project began in March ... root over three years ago with the goal of promoting ...
Breaking Medicine News(10 mins):Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2
... efforts to cut back, , , SATURDAY, April 25 (HealthDay News) ... important lifestyle changes people with heart failure can make, but ... has found. , Researchers asked 116 people with heart ... Though the recommended daily intake of sodium for people with ...
... more potent treatment with fewer side effects , , SATURDAY, ... more direct delivery of cancer drugs to tumors have ... safe, biodegradable polymer, the nanoparticles are chemically engineered to ... most human tumors, and to carry a higher concentration ...
... - Plastic Surgery increased too, with breast implants and ... bank balances and stunning senior celebs are influencing factors.MANCHESTER, ... has been seen by staff at Transform, the UK,s ... Botox Grannies.More and more women over 60 are having ...
... Research , an association of technology analysts, market researchers, and science ... for expanding the pool of associates and tripling of publication schedule ... ... 2009 -- STIX Market Research , an association of technology ...
... a person,s insurance coverage affect their access to quality ... Center, insurance coverage may not only affect a patient,s ... care they receive. Research findings, presented today at the ... a national debate on healthcare reform. , "We ...
... Ill., April 24 World Veterinary Day, April 25, ... farmers. "This year,s theme, ,Veterinarians and Livestock ... partnership, highlights a discipline of veterinary medicine ... said Dr. W. Ron DeHaven, DVM, MBA, Chief Executive ...
Cached Medicine News:Health News:Hidden Salt in Diet Haunts Many With Heart Failure 2Health News:Nanoparticles May Help Attack Cancer More Directly 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 2Health News:Growth of Plastic Surgery & Botox Grannies in UK 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 2Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 3Health News:STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase 4Health News:Does a person's insurance coverage affect their access to quality cancer care? 2Health News:AVMA Celebrates World Veterinary Day 2
Alvis foreign body spud 4 3/4 inches, oval curette 1 x 3 mm with fine point....
Foreign body spud angled, lightly rounded tip....
Optik K & Rs bandage lens is a high water content, therapeutic lens which is ideal for practitioners who recognize the importance of a quality bandage lens....
John weiss, wright acrylic globe....
Medicine Products: